RPRX

Repros Therapeutics Inc.
RPRX

Overview Fund Activity
Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

29 hedge funds and large institutions have $2.51M invested in Repros Therapeutics Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
13
Closed
6
Calls
$223K
Puts
$3K
Net Calls
+$220K
Net Calls Change
-$355K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$440K
2
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$44K
3
AIA
3
Allegis Investment Advisors
Idaho
$183K
4
Bank of America
4
Bank of America
North Carolina
$26K

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$0
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$0
3
Connor, Clark & Lunn Investment Management (CC&L)
3
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$0
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$366K
5
BlackRock
5
BlackRock
New York
$315K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
26
Acrospire Investment Management
Illinois
– -$30K -24,881 Closed
Simplex Trading
27
Simplex Trading
Illinois
– -$3K -2,985 Closed
Citigroup
28
Citigroup
New York
– -$1K -985 Closed
1
2